<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Boston Scientific</strong>.</p>
<p>Looking at options history for Boston Scientific (NYSE:BSX) we detected 13 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 69% with bearish.</p>
<p>From the overall spotted trades, 9 are puts, for a total amount of $727,511 and 4, calls, for a total amount of $131,250.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $100.0 for Boston Scientific during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Boston Scientific's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Boston Scientific's whale trades within a strike price range from $95.0 to $100.0 in the last 30 days. </p>
<h3>Boston Scientific Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766080919_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="Options Call Chart" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766080919_0.png"/></p>

<h3>Biggest Options Spotted:</h3>
<p></p><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BSX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$5.9</td>
<td>$5.6</td>
<td>$5.8</td>
<td>$95.00</td>
<td>$435.0K</td>
<td>188</td>
<td align="right">752</td>
</tr>
<tr>
<td>BSX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$100.00</td>
<td>$54.1K</td>
<td>4.2K</td>
<td align="right">118</td>
</tr>
<tr>
<td>BSX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.5</td>
<td>$2.45</td>
<td>$2.5</td>
<td>$97.50</td>
<td>$48.2K</td>
<td>6.1K</td>
<td align="right">338</td>
</tr>
<tr>
<td>BSX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.6</td>
<td>$4.4</td>
<td>$4.6</td>
<td>$100.00</td>
<td>$44.1K</td>
<td>4.2K</td>
<td align="right">500</td>
</tr>
<tr>
<td>BSX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$100.00</td>
<td>$37.3K</td>
<td>4.2K</td>
<td align="right">273</td>
</tr>
</tbody>
</table><p></p>
<h3>About Boston Scientific</h3>
<p>Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.</p>
<p>In light of the recent options history for Boston Scientific, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Boston Scientific's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 7,954,043, the BSX's price is up by 0.13%, now at $94.6. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>What The Experts Say On Boston Scientific</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $128.25.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Boston Scientific, targeting a price of $130. 
* An analyst from BTIG has revised its rating downward to Buy, adjusting the price target to $132. 
* An analyst from Truist Securities persists with their Buy rating on Boston Scientific, maintaining a target price of $120. 
* An analyst from Canaccord Genuity has decided to maintain their Buy rating on Boston Scientific, which currently sits at a price target of $131. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Boston Scientific with Benzinga Pro for real-time alerts.</p>

<p>Recent options activity for Boston Scientific (NYSE:BSX) shows a bearish trend, with 69% of trades being puts. The price window eyed by major investors is between $95.0 and $100.0. Currently, BSX is trading at $94.6, with a slight increase of 0.13%. Analysts have mixed ratings, with target prices ranging from $120 to $132. The stock's RSI suggests it may be approaching overbought territory. The anticipated earnings release is in 48 days.</p>

Decoding Boston Scientific's Options Activity: What's the Big Picture?